Sensex today | Stock Market Live Updates: Sensex drops 350 pts; Nifty at 24,030 as oil rises, traders brace for MSCI rejig volatility
Sensex, Nifty, Share Prices Live Updates: Indian shares fell at open on Monday, with investors bracing for potential volatility from MSCI's index rejig under the new closing auction system, while an escalation in the Iran war and HDFC Bank's CEO resignation could also weigh on sentiment
Financial data displays price trends and movements on a trading screen during market hours
| Photo Credit:
FabrikaCr
S ensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 31st August 2026
The stock of Emcure Pharmaceuticals has been in a long-term uptrend. After hitting a high of ₹2,047.40 on August 10, the price dropped. Nevertheless, the broader rally is intact as key support levels stay valid. Notable support levels are ₹1,850 and ₹1,780. As long as these levels hold, the outlook will be positive. Therefore, we expect the stock to resume the rally either from the current level of ₹1,871 or after a decline to ₹1,780.
Before the end of this year, the scrip can appreciate to ₹2,100. So, go long at ₹1,871 and accumulate at ₹1,800. Place stop-loss at ₹1,720. When the stock rallies to ₹2,000 and ₹2,050, alter the stop-loss to ₹1,925 and ₹2,000 respectively. Book profits at ₹2,100.
(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)
Explore Emcure Pharmaceuticals stock: Buy at ₹1,871, with potential growth to ₹2,100 and key support levels to watch.